WHO - Annex 20 · Best Poster Awards ..... 458 Correct Site Surgery Posters ... 495 List of...
83
Annex 20 THE NETHERLANDS List of dissemination activities, articles and posters
Transcript of WHO - Annex 20 · Best Poster Awards ..... 458 Correct Site Surgery Posters ... 495 List of...
Annex 20THENETHERLANDSList of disseminationactivities, articlesand posters
426The High 5s Project Interim Report
427 Annex 20. THE NETHERLANDS List of dissemination activities, articles and posters
428The High 5s Project Interim Report
429 Annex 20. THE NETHERLANDS List of dissemination activities, articles and posters
430The High 5s Project Interim Report
Annex 21USABaylor’s samplingrequest
432The High 5s Project Interim Report
433 Annex 21. USA Baylor’s sampling request
434The High 5s Project Interim Report
Annex 22Summary of the‘First InternationalHigh 5s HospitalsMeeting’
436The High 5s Project Interim Report
437 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
438The High 5s Project Interim Report
439 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
Introduction ...................................................................................................................................... 440
1st International High 5s Hospital Meeting Information Note ........................................................ 441
Meeting Agenda ................................................................................................................................ 444
Meeting Summary .............................................................................................................................. 446
Instruction for Posters ...................................................................................................................... 457
Best Poster Awards ............................................................................................................................ 458
Correct Site Surgery Posters .............................................................................................................. 461
France ............................................................................................................................................ 462
Germany........................................................................................................................................ 467
Singapore ...................................................................................................................................... 469
Medication Reconciliation Posters .................................................................................................... 473
Australia ........................................................................................................................................ 474
France ............................................................................................................................................ 475
Germany........................................................................................................................................ 482
The Netherlands ............................................................................................................................ 483
Event Analysis Poster ........................................................................................................................ 493
List of Participants.............................................................................................................................. 495
List of Hospitals.................................................................................................................................. 503
440The High 5s Project Interim Report
441 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
442The High 5s Project Interim Report
443 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
444The High 5s Project Interim Report
445 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
446The High 5s Project Interim Report
447 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
448The High 5s Project Interim Report
449 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
450The High 5s Project Interim Report
451 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
452The High 5s Project Interim Report
453 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
454The High 5s Project Interim Report
455 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
456The High 5s Project Interim Report
457 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
458The High 5s Project Interim Report
459 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
460The High 5s Project Interim Report
461 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
462The High 5s Project Interim Report
463 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
464The High 5s Project Interim Report
465 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
466The High 5s Project Interim Report
467 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
468The High 5s Project Interim Report
469 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
470The High 5s Project Interim Report
471 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
472The High 5s Project Interim Report
473 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
474The High 5s Project Interim Report
475 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
476The High 5s Project Interim Report
477 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
478The High 5s Project Interim Report
479 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
480The High 5s Project Interim Report
481 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
482The High 5s Project Interim Report
483 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
484The High 5s Project Interim Report
485 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
486The High 5s Project Interim Report
487 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
488The High 5s Project Interim Report
489 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
490The High 5s Project Interim Report
491 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
492The High 5s Project Interim Report
493 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
494The High 5s Project Interim Report
495 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
496The High 5s Project Interim Report
497 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
498The High 5s Project Interim Report
499 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
500The High 5s Project Interim Report
501 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
502The High 5s Project Interim Report
503 Annex 22. Summary of the ‘First International High 5s Hospitals Meeting’
504The High 5s Project Interim Report
Credits
506The High 5s Project Interim Report
The Project Director of the report was Agnès Leotsakos, World Health Organization.
The Managing Editor was Dennis O’Leary, President Emeritus of The Joint Commission, USA.
The report was compiled by Hao Zheng, World Health Organization (WHO).
The principal authors and reviewers of this report were:
Margaret Duguid from the Australian Commission on Safety and Quality in Health Care.
Carolyn Hoffman representing the Canadian Patient Safety Institute.
Margaret Colquhoun from the Institute for Safe Medication Practices Canada.
Anne Broyart from the National Authority for Health-HAS, France.
Liat Fishman from the Agency for Quality in Medicine, Germany.
Erica van der Schrieck-de Loos from the CBO Dutch Institute for Healthcare Improvement
(a TNO company).
Katherine Soh from the Ministry of Health, Singapore.
Ingrid Allan from the Ministry of Health, Trinidad and Tobago.
Jeremiah C. Bowman from the American College of Surgeons.
Richard J. Croteau, Anupam Dayal, Jerod M. Loeb, Brette Tschurtz and Scott Williams
from The Joint Commission and Joint Commission International.
Agnès Leotsakos and Hao Zheng from WHO.
Editing was provided by Richard J. Croteau, Anupam Dayal, Margaret Duguid and
Erica van der Schrieck-de Loos.
Valuable input to the High5s Project design and implementation was received from many individuals
who are active participants to the Project or who are no longer part of it. These are:
Sir Liam Donaldson, WHO Envoy for Patient Safety.
Robin Osborn, Commonwealth Fund, USA.
Helen Stark, the Australian Commission on Safety and Quality in Health Care, Australia.
Paula Beard, the Canadian Patient Safety Institute, Canada.
Charles Bruneau, Claire Chabloz, from the Coordination de l’Evaluation des pratiques professionnelles
en santé en Rhône-Alpes, Bertrice Loulière, Eric Lebihan and Myriam Roudaut from Observatoire
des médicaments et de l’innovation thérapeutique Aquitaine, France.
Christian Thomeczek and Daniela Renner from the Agency for Quality in Medicine, Regine Nellen from the
Ministry of Health, Constanze Lessing and Daniel Berning from the Institute for Patient Safety, Germany.
Annemieke van Groenestijn, Elise Posma, Yvonne Salfischberger and Cule Cucic, CBO Dutch Institute
for Healthcare Improvement (a TNO company), Netherlands.
Peter Lee and Theng Hui Hwen from the Ministry of Health, Ong Biauw Chi from the Singapore General
Hospital, Sophia Ang from the National University Hospital Singapore.
Bill Munier and Deborah Perfetto from the U.S.A. Agency for Healthcare Research and Quality,
Peter Goldschmidt, World Development Groups Inc., Jeremiah Bowman from American College
of Surgeons, Lijian Leo Cai, Mike Gillard from the Wheaton Franciscan Healthcare System, USA.
Martin Fletcher, Kate Beaumont, from the former National Patient Safety Agency, UK.
Paula Wilson, Stacey Barrett, Laura Sutton, Heather Sherman and Karen Timmons from The Joint
Commission and Joint Commission International.
Ed Kelley and Eirini Rousi from the World Health Organization.
World Health Organization
20 Avenue Appia
CH-1211 Geneva 27
Switzerland
Tel.: +41 22 791 5060
Please visit us at:
http://www.who.int/patientsafety/implementation/solutions/high5s/en
https://www.high5s.org
